These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 2805939)

  • 1. [Quantitative DNA analysis in epithelial ovarian cancer].
    Xu Y; Cai GR
    Zhonghua Fu Chan Ke Za Zhi; 1989 May; 24(3):156-8, 189. PubMed ID: 2805939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A quantitative study on nuclear DNA content and morphological parameters in ovarian cystadenocarcinoma].
    Liu C; Zhao Y; Sun X
    Zhonghua Fu Chan Ke Za Zhi; 1995 Dec; 30(12):738-40. PubMed ID: 8728920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear deoxyribonucleic acid heterogeneity of ovarian borderline malignant serous tumors.
    Fu YS; Ro J; Reagan JW; Hall TL; Berek J
    Obstet Gynecol; 1986 Apr; 67(4):478-82. PubMed ID: 3960418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic relevance of ploidy, proliferation, and resistance-predictive tests in ovarian carcinoma.
    Volm M; Brüggemann A; Günther M; Kleine W; Pfleiderer A; Vogt-Schaden M
    Cancer Res; 1985 Oct; 45(10):5180-5. PubMed ID: 4027994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of nuclear DNA content in serous ovarian tumors.
    Erhardt K; Auer G; Björkholm E; Forsslund G; Moberger B; Sifverswärd C; Wicksell G; Zetterberg A
    Cancer Res; 1984 May; 44(5):2198-202. PubMed ID: 6713406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Image analysis of cellular DNA content in peritoneal fluid of patients with ovarian tumors of low malignant potential and invasive epithelial ovarian cancer.
    Guidozzi F; Szumel RC; Ball JH; Johnston DA; Katz RL; Kidd L
    Gynecol Oncol; 1996 May; 61(2):204-9. PubMed ID: 8626133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometry as a tool for the prognostic assessment of patients with lung and ovarian carcinomas.
    Volm M; Drings P; Kleine W; Mattern J
    Strahlenther Onkol; 1987 Dec; 163(12):791-4. PubMed ID: 2827331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of DNA content in epithelial ovarian cancer.
    Gajewski WH; Fuller AF; Pastel-Ley C; Flotte TJ; Bell DA
    Gynecol Oncol; 1994 Apr; 53(1):5-12. PubMed ID: 8175021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
    Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
    Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical and two-parameter flow cytometric studies of DNA topoisomerase II alpha in human epithelial ovarian carcinoma and germ cell tumor.
    Tanoguchi K; Sasano H; Yabuki N; Kikuchi A; Ito K; Sato S; Yajima A
    Mod Pathol; 1998 Feb; 11(2):186-93. PubMed ID: 9504690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis and prognosis of ovarian epithelial tumor with morphometry].
    Yin TJ; Gu MJ
    Ai Zheng; 2002 Jul; 21(7):781-4. PubMed ID: 12479107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relation between DNA content in ovarian cystadenoma and its pathohistology].
    Sun ZC
    Zhonghua Fu Chan Ke Za Zhi; 1993 Dec; 28(12):731-3, 760-1. PubMed ID: 8137645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometry as a prognostic indicator in women with borderline epithelial ovarian tumors.
    Harlow BL; Fuhr JE; McDonald TW; Schwartz SM; Beuerlein FJ; Weiss NS
    Gynecol Oncol; 1993 Sep; 50(3):305-9. PubMed ID: 8406192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survivin expression and its correlation with cell proliferation and prognosis in epithelial ovarian tumors.
    Sui L; Dong Y; Ohno M; Watanabe Y; Sugimoto K; Tokuda M
    Int J Oncol; 2002 Aug; 21(2):315-20. PubMed ID: 12118327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA ploidy, proliferative index, and epidermal growth factor receptor: expression and prognosis in patients with gastric cancers.
    D'Agnano I; D'Angelo C; Savarese A; Carlini M; Garofalo A; Bottari L; Santoro E; Giannarelli D; Vecchione A; Zupi G
    Lab Invest; 1995 Apr; 72(4):432-8. PubMed ID: 7723282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
    Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of histologic grading in the prognosis of epithelial ovarian carcinoma.
    Sorbe B; Frankendal B; Veress B
    Obstet Gynecol; 1982 May; 59(5):576-82. PubMed ID: 7070728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression and clinical significance of uPA and PAI-1 in epithelial ovarian cancer].
    Cai Z; Li YF; Liu FY; Feng YL; Hou JH; Zhao MQ
    Ai Zheng; 2007 Mar; 26(3):312-7. PubMed ID: 17355798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of circulating cell-free nuclear and mitochondrial DNA in benign and malignant ovarian tumors.
    Zachariah RR; Schmid S; Buerki N; Radpour R; Holzgreve W; Zhong X
    Obstet Gynecol; 2008 Oct; 112(4):843-50. PubMed ID: 18827127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ferritin levels of ascites and the contents of cystic ovarian tumors--possibilities of ferritin production and secretion by malignant tumor cells].
    Okamoto M; Fukasawa H; Hirata F; Hoshi S
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):240-6. PubMed ID: 6696460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.